A Director at Mednax Inc (NYSE: MD) is Selling Shares

Today, a Director at Mednax Inc (MDResearch Report), Pascal Goldschmidt, sold shares of MD for $100.3K.

See today’s analyst top recommended stocks >>

Based on Mednax Inc’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $933 million and quarterly net profit of $60.21 million. In comparison, last year the company earned revenue of $911 million and had a net profit of $136 million. MD’s market cap is $2.69B and the company has a P/E ratio of 10.46. Currently, Mednax Inc has an average volume of 1.44M.

Based on 8 analyst ratings, the analyst consensus is Hold with an average price target of $38.13, reflecting a 26.9% upside.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.

Leave a Reply

Your email address will not be published. Required fields are marked *